Publication | Open Access
Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy
33
Citations
0
References
2019
Year
Clinical ImmunologyCancer ImmunosurveillanceAutoimmune DiseaseClinical ResponsesImmunologyPd-l1/pd-1 Blockade TherapyAutoimmunityT Cell ImmunityCd4 T Cell ResponsesImmunomodulationImmunosuppressionImmunotherapyMedicine
No additional data available for this publication yet. Check back later!